Saratoga Investment Stock (NYSE:SAR), Trade Ideas

Saratoga Investment

Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The company invests in senior and unitranche leveraged loans and mezzanine debt and, to a lesser extent, equity issued by private U.S. middle-market companies, which it defines as companies having annual earnings before interest, taxes, depreciation and amortization (EBITDA) under $50 million, both through direct lending and through participation in loan syndicates.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ACRS

AEHR

AIMD

AMRN

CMND

DCGO

ETWO

EXAI

GDRX

GRTX

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

ICCT

ISRG

KITT

MDRX

NAMS

NEXI

NVCR

NVNI

PRST

PSMT

RBOT

ROMA

SANA

SATS

SIDU

TCRT

TGTX

WDFC

WLDS

XCUR

XERS

Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.

Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

ALTM

CHRS

COIN

GLUE

IRBT

MIRM

TLRY

WOLF

U.S. stocks traded slightly higher, with the Dow Jones index gaining over 20 points on Wednesday.

Shares of Veradigm Inc.  (NASDAQ: MDRX) shares fell sharply during Wednesday’s session.

Veradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesday

Earnings

Pre-Market Outlook

NEOG

With U.S. stock futures trading slightly higher on Tuesday morning, some of the stocks that may grab investor focus today are as follows:

PepsiCo, Neogen And 3 Stocks To Watch Heading Into Tuesday

Saratoga Investment Corp

SARASELECT NAMEN -ANTEILE by SARASELECT

Sarcophagus

Sanford Ltd

SABRE RESOURCES LTD by Sabre Resources Ltd.

Sabre Resources Ltd

AXS Short Innovation Daily ETF

SOUTHERN ARC MINERLS A by Southern Arc Minerals Inc.

Southern Arc Minerals Inc

Sartorius AG

Saratoga Investment Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) ("Saratoga Investment" or "the Company"), a business development company, today announced that its Board of Directors has declared a quarterly dividend of $0.73 per share for the fiscal fourth quarter ended February 29, 2024, an increase of $0.01 from $0.72 per share in the prior fiscal third quarter, and the sixteenth quarterly dividend increase in a row. Total dividends for fiscal year 2024 are $2.85 per share, an increase of 16.8% over the prior year. This fourth quarter dividend is payable on March 28, 2024, to all stockholders of record at the close of business on March 13, 2024.
"We continue to benefit from the elevated level of interest rates on our largely floating rate assets combined with the growth of our overall portfolio in well-selected industry segments, resulting in healthy earnings growth this past year," said&nbsp;Christian L. Oberbeck, Chairman and Chief Executive Officer of&nbsp;Saratoga Investment. "Saratoga's fourth quarter dividend of 73c per share reflects an approximately 6% increase year-over-year and a 38% increase over the past two years. Annualizing this dividend rate implies a 12.8% dividend yield based on Saratoga's recent stock price of&nbsp;$22.77&nbsp;per share on&nbsp;February 13, 2024. Our current substantial overearning of the dividend increases Net Asset Value, supports increased portfolio growth and provides a cushion against adverse events, including potential cuts in interest rates in 2024."
This is the fourth dividend declared in fiscal year 2024. Total dividends for fiscal year 2024 are $2.85 per share, an increase of 16.8% over the prior year's total dividends of $2.44 per share. The Company previously declared a quarterly dividend of $0.72 per share for the quarter ended November 30, 2023, $0.71 per share for the quarter ended August 31, 2023 and $0.70 per share for the quarter ended May 31, 2023. During fiscal 2023 the Company declared a quarterly dividend of $0.69 per share for the quarter ended February 28, 2023, $0.68 per share for the quarter ended November 30, 2022, $0.54 per share for the quarter ended August 31, 2022 and $0.53 per share for the quarter ended May 31, 2022.
Shareholders will have the option to receive payment of the dividend in cash or receive shares of common stock pursuant to the Company's dividend reinvestment plan ("DRIP"). Saratoga Investment shareholders who hold their shares with a broker must affirmatively instruct their brokers prior to the record date if they prefer to receive this dividend, and future dividends, in common stock.&nbsp; The number of shares of common stock to be delivered shall be determined by dividing the total dollar amount by 95% of the average of the market prices per share at the close of trading on the ten (10) trading days immediately preceding (and including) the payment date.

Dividends

Saratoga Investment Corp. Increases Quarterly Dividend From $0.72 To $0.73 Per Share

Shares of WD-40 Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wdfc#NASDAQ">WDFC</a>) rose sharply during Wednesday&rsquo;s session after the company reported better-than-expected first-quarter results.
WD-40 reported quarterly earnings of $1.28 per share which exceeded the analyst consensus estimate of $1.05 per share. The company reported quarterly sales of $140.42 million, clocking in above the Street&#39;s estimate of $134.37 million.
WD-40 shares jumped 17.3% to $277.56 on Wednesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Nauticus Robotics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kitt#NASDAQ">KITT</a>) climbed 87.8% to $0.5501. Nauticus Robotics secured additional funding and appointed John W. Gibson, Jr as interim CEO.</li>
<li>Clearmind Medicine Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmnd#NASDAQ">CMND</a>) shares jumped 47.7% to $3.0570. Clearmind Medicine completed a Type A Meeting with the FDA for clinical trial of its proprietary MEAI-based, CMND-100 compound, for the treatment of alcohol use disorder.</li>
<li>Sana Biotechnology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sana#NASDAQ">SANA</a>) gained 46.8% to $7.57. Sana Biotechnology recently announced FDA clearance of investigational new drug application for SC262.</li>
<li>Ucommune International Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uk#NASDAQ">UK</a>) jumped 37.8% to $4.98.</li>
<li>Vicarious Surgical Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rbot#NASDAQ">RBOT</a>) rose 37% to $0.6851.</li>
<li>Nvni Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvni#NASDAQ">NVNI</a>) climbed 35.2% to $2.6091.</li>
<li>EchoStar Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sats#NASDAQ">SATS</a>) gained 31% to $16.50. EchoStar completed merger with DISH Network Corporation.</li>
<li>Amarin Corporation plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amrn#NASDAQ">AMRN</a>) climbed 28.8% to $1.25 after the company reported strong preliminary FY23 total revenues.</li>
<li>Exicure, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xcur#NASDAQ">XCUR</a>) shares rose 17% to $0.5501. Exicure was granted broad U.S. patent #11866700 for &quot;Liposomal Nucleic Acid Constructs Presenting Antisense Oligonucleotides For Knockdown Of Interleukin 17 Mrna (For Inflammation From Cancer, Obesity, Diabetes, Alzheimer&#39;s).&quot;</li>
<li>NexImmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nexi#NASDAQ">NEXI</a>) gained 16.2% to $13.72.</li>
<li>Exscientia plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/exai#NASDAQ">EXAI</a>) rose 14% to $7.07. B of A Securities recently downgraded the stock from Buy to Neutral and lowered its price target from $11 to $9.</li>
<li>NewAmsterdam Pharma Company N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nams#NASDAQ">NAMS</a>) rose 13.6% to $14.00.</li>
<li>SMART Global Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgh#NASDAQ">SGH</a>) gained 13.4% to $20.97 after the companyy posted better-than-expected earnings for its first quarter and announced approval of $75 million share repurchase authorization.</li>
<li>Xeris Biopharma Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xers#NASDAQ">XERS</a>) jumped 12.4% to $2.7100. Xeris Biopharma entered into an exclusive worldwide license agreement with Amgen for Xeriject formulation of teprotumumab for thyroid eye disease.</li>
<li>GoodRx Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gdrx#NASDAQ">GDRX</a>) jumped 11.6% to $6.38. GoodRx sees preliminary FY23 adjusted revenue of $759 million to $761 million.</li>
<li>E2open Parent Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/etwo#NYSE">ETWO</a>) surged 11.2% to $4.27 following strong quarterly sales.</li>
<li>PriceSmart, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/psmt#NASDAQ">PSMT</a>) rose 10% to $80.25 as the company reported better-than-expected earnings for its first quarter on Tuesday.</li>
<li>iCoreConnect Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icct#NASDAQ">ICCT</a>) shares rose 9.3% to $1.4203. iCoreConnect announced strategic acquisition of Verifi Dental.</li>
<li>AZZ Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/azz#NYSE">AZZ</a>) jumped 9.1% to $62.24 following upbeat quarterly results.</li>
<li>Intuitive Surgical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/isrg#NASDAQ">ISRG</a>) gained 6.1% to $350.63. Intuitive Surgical said it sees preliminary revenue of $1.93 billion for the fourth quarter, versus market estimates of $1.87 billion.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>DocGo Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dcgo#NASDAQ">DCGO</a>) shares fell 32.9% to $3.2150. Fuzzy Panda Research issued a report and disclosed a short position in the stock.</li>
<li>HWH International Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hwh#NASDAQ">HWH</a>) shares fell 25.3% to $2.10 after dipping 26% on Tuesday.</li>
<li>Aclaris Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acrs#NASDAQ">ACRS</a>) fell 25% to $0.9601 after the company&#39;s Phase 2B study of ATI-1777 2% QD was not statistically superior on the primary efficacy endpoint.</li>
<li>Presto Automation Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prst#NASDAQ">PRST</a>) fell 19.5% to $0.3127.</li>
<li>Roma Green Finance Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roma#NASDAQ">ROMA</a>) shares fell 18.8% to $2.3557 after dipping over 27% on Tuesday. Roma Green Finance announced pricing of $12.3 million public offering of 2,449,943 of shares at price of $4.00 per share.</li>
<li>Sidus Space, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sidu#NASDAQ">SIDU</a>) fell 16.8% to $14.11. Sidus Space regained compliance with Nasdaq minimum bid requirements.</li>
<li>Wearable Devices Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wlds#NASDAQ">WLDS</a>) fell 15.7% to $0.3797.</li>
<li>Aehr Test Systems (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aehr#NASDAQ">AEHR</a>) shares fell 15.1% to $18.97 after the company lowered its full-year revenue guidance.</li>
<li>Ainos, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aimd#NASDAQ">AIMD</a>) fell 14.9% to $2.22.</li>
<li>GrafTech International Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eaf#NYSE">EAF</a>) fell 14.4% to $1.61.</li>
<li>Alaunos Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcrt#NASDAQ">TCRT</a>) declined 12.9% to $0.1335.</li>
<li>TG Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tgtx#NASDAQ">TGTX</a>) fell 12.4% to $18.38 after the company reported preliminary BRIUMVI US net product sales for Q4 and FY23.</li>
<li>Wheels Up Experience Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/up#NYSE">UP</a>) fell 12% to $4.2350.</li>
<li>MicroCloud Hologram Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holo#NASDAQ">HOLO</a>) fell 11.9% to $0.2621 after gaining 22% on Tuesday.</li>
<li>Veradigm Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdrx#NASDAQ">MDRX</a>) fell 11.1% to $9.56. Veradigm said it sees FY23 revenue of $608 million to $622 million.</li>
<li>Galera Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grtx#NASDAQ">GRTX</a>) shares fell 9.1% to $0.1919 after jumping 41% on Tuesday.</li>
<li>Saratoga Investment Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sar#NYSE">SAR</a>) fell 9.1% to $23.55 following downbeat quarterly earnings.</li>
<li>NovoCure Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvcr#NASDAQ">NVCR</a>) declined 8.8% to $13.43.</li>
<li>Sasol Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ssl#NYSE">SSL</a>) shares fell 6.8% to $9.08.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/01/36571171/how-to-earn-500-a-month-from-jpmorgan-stock-ahead-of-q4-earnings-report"> How To Earn $500 A Month From JPMorgan Stock Ahead Of Q4 Earnings Report</a>

Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

U.S. stocks traded slightly higher, with the Dow Jones index gaining over 20 points on Wednesday.
Shares of Veradigm Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdrx#NASDAQ">MDRX</a>) shares fell sharply during Wednesday&rsquo;s session.
Veradigm said it sees FY23 revenue of $608 million to $622 million. The company also sees FY23 Non-GAAP EPS of 79 cents to 88 cents.
Veradigm shares tumbled 11.1% to $9.56 on Wednesday.
Here are some other big stocks recording losses in today&rsquo;s session.
<ul>
<li>DocGo Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dcgo#NASDAQ">DCGO</a>) shares dipped 32.9% to $3.2150. Fuzzy Panda Research issued a report and disclosed a short position in the stock.</li>
<li>Aehr Test Systems (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aehr#NASDAQ">AEHR</a>) shares declined 15.1% to $18.97 after the company lowered its full-year revenue guidance.</li>
<li>GrafTech International Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eaf#NYSE">EAF</a>) shares tumbled 14.4% to $1.61.</li>
<li>TG Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tgtx#NASDAQ">TGTX</a>) declined 12.4% to $18.38 after the company reported preliminary BRIUMVI US net product sales for Q4 and FY23.</li>
<li>Wheels Up Experience Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/up#NYSE">UP</a>) declined 12% to $4.2350.</li>
<li>Monte Rosa Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glue#NASDAQ">GLUE</a>) fell 10.2% to $6.92.</li>
<li>Saratoga Investment Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sar#NYSE">SAR</a>) declined 9.1% to $23.55 following downbeat quarterly earnings.</li>
<li>NovoCure Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvcr#NASDAQ">NVCR</a>) dipped 8.8% to $13.43.</li>
<li>Coherus BioSciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chrs#NASDAQ">CHRS</a>) fell 8.3% to $2.73. Coherus Biosciences announced the termination of its tigit program collaboration with Shanghai Junshi Biosciences, with plans to wind down their work in the coming months.</li>
<li>Tilray Brands, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tlry#NASDAQ">TLRY</a>) fell 8.1% to $1.94. Tilray filed prospectus supplement to register the resale of 12.4 million shares of common stock by selling stockholder.</li>
<li>Mirum Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mirm#NASDAQ">MIRM</a>) fell 7.7% to $25.75. Mirum Pharmaceuticals recently announced preliminary unaudited 2023 net revenue and issued corporate updates.</li>
<li>Sasol Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ssl#NYSE">SSL</a>) shares declined 6.8% to $9.08.</li>
<li>Wolfspeed, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wolf#NYSE">WOLF</a>) fell 6.7% to $37.35.</li>
<li>3D Systems Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ddd#NYSE">DDD</a>) fell 6.2% to $5.41.</li>
<li>iRobot Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/irbt#NASDAQ">IRBT</a>) fell 6.1% to $34.81.</li>
<li>Arcadium Lithium plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/altm#NASDAQ">ALTM</a>) fell 6% to $6.11.</li>
<li>Coinbase Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>) shares declined 4.7% to $144.85 after the SEC&#39;s X account was compromised on Tuesday. The SEC said it has not approved the listing and trading of spot <a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment/">bitcoin</a> exchange-traded products.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/01/36577360/dow-surges-100-points-pricesmart-earnings-top-views"> Dow Surges 100 Points; PriceSmart Earnings Top Views</a>

Compass Point analyst Casey Alexander downgrades Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) from Buy to Neutral and announces $24.75 price target.

Downgrades

Price Target

Analyst Ratings

Compass Point Downgrades Saratoga Investment to Neutral, Announces $24.75 Price Target

Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) reported its Q3 earnings results on Tuesday, January 9, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Saratoga Investment missed estimated earnings by 1.94%, reporting an EPS of $1.01 versus an estimate of $1.03.
Revenue was up $10.08 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.0 which was followed by a 2.15% drop in the share price the next day.
Here's a look at Saratoga Investment's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.08</td>
<td>0.85</td>
<td>0.78</td>
<td>0.62</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.08</td>
<td>1.08</td>
<td>0.98</td>
<td>0.77</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>35.36M</td>
<td>31.07M</td>
<td>27.59M</td>
<td>23.54M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>35.51M</td>
<td>34.63M</td>
<td>32.31M</td>
<td>26.26M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Saratoga Investment <a href="https://www.benzinga.com/quote/SAR/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Saratoga Investment: Q3 Earnings Insights

Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) reported quarterly earnings of $1.01 per share which missed the analyst consensus estimate of $1.03 by 1.94 percent. This is a 31.17 percent increase over earnings of $0.77 per share from the same period last year. The company reported quarterly sales of $36.34 million which beat the analyst consensus estimate of $36.08 million by 0.72 percent. This is a 38.40 percent increase over sales of $26.26 million the same period last year.

Earnings Beats

Earnings Misses

Saratoga Investment Q3 EPS $1.01 Misses $1.03 Estimate, Sales $36.34M Beat $36.08M Estimate

<h3>Companies Reporting Before The Bell</h3>
&bull; TD Synnex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNX#NYSE">SNX</a>) is likely to report quarterly earnings at $2.68 per share on revenue of $14.47 billion.
&bull; Tilray Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) is projected to report quarterly loss at $0.06 per share on revenue of $195.10 million.
&bull; Neogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEOG#NASDAQ">NEOG</a>) is estimated to report quarterly earnings at $0.13 per share on revenue of $235.53 million.
&bull; MSC Industrial Direct Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSM#NYSE">MSM</a>) is projected to report quarterly earnings at $1.31 per share on revenue of $972.06 million.
&bull; Acuity Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AYI#NYSE">AYI</a>) is estimated to report quarterly earnings at $3.20 per share on revenue of $932.13 million.
&bull; Albertsons Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>) is estimated to report quarterly earnings at $0.65 per share on revenue of $18.37 billion.
<h3>Companies Reporting After The Bell</h3>
&bull; Park Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKE#NYSE">PKE</a>) is likely to report earnings for its third quarter.
&bull; VOXX International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOXX#NASDAQ">VOXX</a>) is estimated to report quarterly loss at $0.10 per share on revenue of $127.22 million.
&bull; AZZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZZ#NYSE">AZZ</a>) is expected to report quarterly earnings at $1.00 per share on revenue of $374.73 million.
&bull; E2open Parent Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETWO#NYSE">ETWO</a>) is projected to report quarterly earnings at $0.04 per share on revenue of $154.46 million.
&bull; SMART Glb Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGH#NASDAQ">SGH</a>) is estimated to report quarterly earnings at $0.16 per share on revenue of $275.00 million.
&bull; WD-40 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDFC#NASDAQ">WDFC</a>) is projected to report quarterly earnings at $1.05 per share on revenue of $134.37 million.
&bull; Pricesmart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSMT#NASDAQ">PSMT</a>) is estimated to report quarterly earnings at $1.09 per share on revenue of $1.16 billion.
&bull; CalAmp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) is expected to report quarterly loss at $0.03 per share on revenue of $56.20 million.
&bull; Aehr Test Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) is estimated to report quarterly earnings at $0.19 per share on revenue of $20.88 million.
&bull; Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) is estimated to report quarterly earnings at $1.03 per share on revenue of $36.08 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

CAMP

VOXX

Earnings Scheduled For January 9, 2024

Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) is set to give its latest quarterly earnings report on Tuesday, 2024-01-09. Here's what investors need to know before the announcement.
Analysts estimate that Saratoga Investment will report an earnings per share (EPS) of $1.03. 
Saratoga Investment bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
Last quarter the company missed EPS by $0.00, which was followed by a 2.15% drop in the share price the next day.
Here's a look at Saratoga Investment's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.08</td>
<td>0.85</td>
<td>0.78</td>
<td>0.62</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.08</td>
<td>1.08</td>
<td>0.98</td>
<td>0.77</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-2.15%</td>
<td>-3.9%</td>
<td>0.08%</td>
<td>-0.11%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1704726014_0_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Saratoga Investment were trading at $26.35 as of January 05. Over the last 52-week period, shares are down 3.48%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/SAR/earnings">To track all earnings releases for Saratoga Investment visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Preview Of Saratoga Investment's Earnings

B. Riley Securities analyst Bryce Rowe downgrades Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) from Buy to Neutral and announces $28 price target.

B. Riley Securities Downgrades Saratoga Investment to Neutral, Announces $28 Price Target

Saratoga Investment Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) ("Saratoga Investment" or "the Company"), a business development company, today announced that its Board of Directors has declared a quarterly dividend of $0.72 per share for the fiscal third quarter ended November 30, 2023, an increase of $0.01 from $0.71 per share in the prior fiscal second quarter, and the fifteenth quarterly dividend increase in a row. This dividend is payable on December 28, 2023, to all stockholders of record at the close of business on December 11, 2023.
"We continue to benefit from the absolute level of interest rates on our largely floating rate assets, which when combined with the recent growth of our overall portfolio, its high-quality nature and resilient performance and our largely fixed rate liabilities, have resulted in record earnings," said&nbsp;Christian L. Oberbeck, Chairman and Chief Executive Officer of&nbsp;Saratoga Investment. "Saratoga's third quarter dividend of 72c per share reflects an approximately 6% increase year-over-year and a 36% increase over the past two years. Annualizing this dividend rate, coupled with our last reported quarterly adjusted net investment income of $1.08 per share, imply an 11.5% dividend yield, and importantly, a 17.2% earnings yield based on Saratoga's recent stock price of&nbsp;$25.06&nbsp;per share on&nbsp;November 13, 2023."
This is the third dividend declared in fiscal year 2024. The Company previously declared a quarterly dividend of $0.71 per share for the quarter ended August 31, 2023 and $0.70 per share for the quarter ended May 31, 2023. During fiscal 2023 the Company declared a quarterly dividend of $0.69 per share for the quarter ended February 28, 2023, $0.68 per share for the quarter ended November 30, 2022, $0.54 per share for the quarter ended August 31, 2022 and $0.53 per share for the quarter ended May 31, 2022. During fiscals 2022 and 2021 the Company declared a total dividend of $2.45 per share and $1.23 per share, respectively.
Shareholders will have the option to receive payment of the dividend in cash or receive shares of common stock pursuant to the Company's dividend reinvestment plan ("DRIP"). Saratoga Investment shareholders who hold their shares with a broker must affirmatively instruct their brokers prior to the record date if they prefer to receive this dividend, and future dividends, in common stock.&nbsp; The number of shares of common stock to be delivered shall be determined by dividing the total dollar amount by 95% of the average of the market prices per share at the close of trading on the ten (10) trading days immediately preceding (and including) the payment date.

Saratoga Investment Corp. Increases Quarterly Dividend From $0.71 To $0.72 Per Share

With U.S. stock futures trading slightly higher on Tuesday morning, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>PepsiCo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pep#NASDAQ">PEP</a>) reported Q3 earnings of&nbsp;$2.25 per share on revenue of $23.45 billion before the opening bell. PepsiCo shares gained 2.2% to $165.00 in pre-market&nbsp;trading.</li>
<li>Saratoga Investment Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sar#NYSE">SAR</a>) posted better-than-expected sales for its fiscal second quarter on Monday. Saratoga Investment shares gained 1.5% to $24.50 in the after-hours trading session.</li>
<li>Neogen Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/neog#NASDAQ">NEOG</a>) reported earnings of&nbsp;11&nbsp;cents per share on revenue of $228.9 million for the latest quarter before the bell on Tuesday. Neogen shares were down 3.3% to $16.40&nbsp;in pre-market trading on Tuesday.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
<ul>
<li>PagerDuty, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pd#NYSE">PD</a>) reported a proposed private placement of $350 million of convertible senior notes. PagerDuty shares declined 5.6% to $20.60 in the after-hours trading session on Monday.</li>
<li>Analysts expect AZZ Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/azz#NYSE">AZZ</a>) to post quarterly earnings at $1.08 per share on revenue of $396.91 million after the closing bell. AZZ shares gained 1.9% to $46.37 in after-hours trading.</li>
</ul>
Read This Next: <a href="https://www.benzinga.com/news/earnings/23/10/35145201/walgreens-likely-to-report-lower-q4-earnings-heres-a-look-at-recent-price-target-changes-by-the-mos"> Walgreens Likely To Report Lower Q4 Earnings; Here&#39;s A Look At Recent Price Target Changes By The Most Accurate Analysts </a>

Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) reported quarterly earnings of $1.08 per share which met the analyst consensus estimate. This is a 86.21 percent increase over earnings of $0.58 per share from the same period last year. The company reported quarterly sales of $35.51 million which beat the analyst consensus estimate of $35.36 million by 0.44 percent. This is a 62.51 percent increase over sales of $21.85 million the same period last year.

Saratoga Investment Q2 EPS $1.08, Inline, Sales $35.51M Beat $35.36M Estimate

With U.S. stock futures trading lower&nbsp;Monday morning, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expected&nbsp;Applied Digital Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apld#NASDAQ">APLD</a>) to report a quarterly loss at 2 cents per share on revenue of $34.58 million before the opening bell. The company reported adjusted EPS of less than 1 penny, beating the Street estimate, and sales of $36.3 million, sending the stock higher premarket.&nbsp;</li>
<li>Conifer Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnfr#NASDAQ">CNFR</a>) said James Petcoff will be stepping down as Chairman and Co-CEO. The company announced that Nick Petcoff will become sole CEO, effective Dec. 31, 2023. Conifer shares gained 0.9% to close at $1.17 on Friday.</li>
<li>Analysts are expecting Saratoga Investment Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sar#NYSE">SAR</a>) to have earned $1.08 per share on revenue of $35.36 million for the latest quarter. The company will release earnings after the markets close. Saratoga Investment shares gained 2.4% to $24.83 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here</a>.
<ul>
<li>Niu Technologies (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/niu#NASDAQ">NIU</a>) issued a sales volume update for the third quarter; The company sold a total of 265,923 units during the quarter. Niu Technologies shares gained 3.1% to $2.66 in the after-hours trading session.</li>
<li>Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bhat#NASDAQ">BHAT</a>) filed for a mixed shelf of up to $150 million. Fujian Blue Hat Interactive Entertainment Technology shares fell 1.5% to $1.35 in after-hours trading.</li>
</ul>
Read This Next: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/10/35125446/kirklands-and-2-other-stocks-under-3-insiders-are-buying"> Kirkland&#39;s And 2 Other Stocks Under $3 Insiders Are Buying </a>

APLD

BHAT

CNFR

Applied Digital, Saratoga Investment And 3 Stocks To Watch Heading Into Monday

The CNN Money Fear and Greed index showed some easing in the fear level, moving from &quot;Extreme Fear&quot; to the &quot;Fear&quot; zone on Friday.
U.S. stocks settled higher on Friday, as investors <a href="https://www.benzinga.com/government/23/10/35128961/economists-reassess-feds-next-moves-after-septembers-stunning-job-numbers">digested the recent jobs data.</a> The S&amp;P 500 closed the week higher by around 0.48%, snapping a four-week losing streak. However, the Dow Jones closed down 0.30% last week.
U.S. nonfarm payrolls rose by 336,000 in September, versus a revised 227,000 increase in August, and compared to market estimates of 170,000. Average hourly earnings increased by 0.2% to $33.88 in September, the same pace as in the previous month and below market estimates of a 0.3% rise.
Levi Strauss &amp; Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/levi#NYSE">LEVI</a>) shares fell 0.8% on Friday following third-quarter results. The company reported better-than-expected earnings for its third quarter, while sales missed estimates. Pioneer Natural Resources Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pxd#NYSE">PXD</a>) shares jumped more than 10% following a report suggesting Exxon Mobil Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xom#NYSE">XOM</a>) is nearing a $60 billion deal to buy the company.
Most sectors on the S&amp;P 500 closed on a positive note, with information technology and communication services stocks recording the biggest gains on Friday. However, consumer staples stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed higher by around 288 points to 33,407.58 on Friday. The S&amp;P 500 rose 1.18% at 4,308.50, while the Nasdaq Composite jumped 1.60% at 13,431.34 during Friday&rsquo;s session.
Investors are awaiting earnings results from Saratoga Investment Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sar#NYSE">SAR</a>) and Applied Digital Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apld#NASDAQ">APLD</a>) on Monday.
At a current reading of 28.9, the index moved to the &quot;Fear&quot; zone on Friday, compared to a previous reading of 22.1.
What is CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: <a href="https://www.benzinga.com/news/23/10/35124492/hp-zoom-video-and-2-other-stocks-insiders-are-selling"> HP, Zoom Video And 2 Other Stocks Insiders Are Selling</a>
Photo: Shutterstock

LEVI

Fear & Greed Index Moves To 'Fear' Zone Following Jobs Data

<h3>Companies Reporting Before The Bell</h3>
&bull; Applied Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) is estimated to report quarterly loss at $0.02 per share on revenue of $34.58 million.
<h3>Companies Reporting After The Bell</h3>
&bull; Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) is projected to report quarterly earnings at $1.08 per share on revenue of $35.36 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

Earnings Scheduled For October 9, 2023

Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) is set to give its latest quarterly earnings report on Monday, 2023-10-09. Here's what investors need to know before the announcement.
Analysts estimate that Saratoga Investment will report an earnings per share (EPS) of $1.08. 
Saratoga Investment bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company beat EPS by $0.23, which was followed by a 3.9% drop in the share price the next day.
Here's a look at Saratoga Investment's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.85</td>
<td>0.78</td>
<td>0.62</td>
<td>0.32</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.08</td>
<td>0.98</td>
<td>0.77</td>
<td>0.58</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-3.9%</td>
<td>0.08%</td>
<td>-0.11%</td>
<td>1.25%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2023/1696600813_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Saratoga Investment were trading at $24.16 as of October 05. Over the last 52-week period, shares are up 14.38%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/SAR/earnings">To track all earnings releases for Saratoga Investment visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For Saratoga Investment

Saratoga Investment Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) (&quot;Saratoga Investment&quot; or &quot;the Company&quot;), a business development company, today announced that its Board of Directors has declared a quarterly dividend of&nbsp;$0.71&nbsp;per share for the fiscal&nbsp;second quarter&nbsp;ended August 31, 2023, an increase of&nbsp;$0.01&nbsp;from&nbsp;$0.70&nbsp;per share in the prior fiscal&nbsp;first quarter, and the fourteenth quarterly dividend increase in a row. This dividend is payable on September 28, 2023, to all stockholders of record at the close of business on September 14, 2023. 
&nbsp;
&quot;The impact of the absolute level and continued increase in interest rates on our largely floating rate assets, when combined with the growth of our overall portfolio, its resilient performance and our largely fixed rate liabilities, have resulted in record earnings,&quot; said&nbsp;Christian L. Oberbeck, Chairman and Chief Executive Officer of&nbsp;Saratoga Investment. &quot;Saratoga&#39;s&nbsp;second quarter&nbsp;dividend of 71c per share reflects an approximately&nbsp;31%&nbsp;increase year-over-year. Annualizing this dividend rate, coupled with our last reported record quarterly adjusted net investment income of&nbsp;$1.08&nbsp;per share, imply a&nbsp;10.7%&nbsp;dividend yield, and importantly, a&nbsp;16.3%&nbsp;earnings yield based on Saratoga&#39;s recent stock price of&nbsp;$26.57&nbsp;per share on&nbsp;August 11, 2023.&quot;
This is the second dividend declared in fiscal year 2024. The Company previously declared a quarterly dividend of&nbsp;$0.70&nbsp;per share for the quarter ended May 31, 2023. During fiscal 2023 the Company declared a quarterly dividend of&nbsp;$0.69&nbsp;per share for the quarter ended February 28, 2023,&nbsp;$0.68&nbsp;per share for the quarter ended November 30, 2022,&nbsp;$0.54&nbsp;per share for the quarter ended August 31, 2022 and&nbsp;$0.53&nbsp;per share for the quarter ended May 31, 2022. During fiscals 2022 and 2021 the Company declared a total dividend of&nbsp;$2.45&nbsp;per share and&nbsp;$1.23&nbsp;per share, respectively.
Shareholders will have the option to receive payment of the dividend in cash or receive shares of common stock pursuant to the Company&#39;s dividend reinvestment plan (&quot;DRIP&quot;). Saratoga Investment shareholders who hold their shares with a broker must affirmatively instruct their brokers prior to the record date if they prefer to receive this dividend, and future dividends, in common stock.&nbsp; The number of shares of common stock to be delivered shall be determined by dividing the total dollar amount by&nbsp;95%&nbsp;of the average of the market prices per share at the close of trading on the ten (10) trading days immediately preceding (and including) the payment date.

Saratoga Investment Corp. Increases Quarterly Dividend From $0.70 To $0.71 Per Share

Upgrades

Initiation

ALKT

ALTI

ATVI

BlackSky Technology Inc. Class A Common Stock

BKSY

CACI

CSCO

DKNG

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

GTLS

HITI

HLLY

IART

ITRI

JKHY

MODN

NCNO

QTWO

QUAD

RDFN

SILK

SPWR

STLA

TEAM

TKNO

Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2023

Raymond James analyst Robert Dodd downgrades Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) from Outperform to Market Perform.

Raymond James Downgrades Saratoga Investment to Market Perform

Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) reported quarterly earnings of $1.08 per share which beat the analyst consensus estimate of $0.85 by 27.06 percent. This is a 103.77 percent increase over earnings of $0.53 per share from the same period last year. The company reported quarterly sales of $34.62 million which beat the analyst consensus estimate of $31.07 million by 11.44 percent. This is a 85.36 percent increase over sales of $18.68 million the same period last year.

Saratoga Investment Q1 EPS $1.08 Beats $0.85 Estimate, Sales $34.62M Beat $31.07M Estimate

Saratoga Investment (SAR) has disclosed a new risk, in the Debt & Financing category. Saratoga Investment faces negligible concern regarding Item 3...

A New Cause for Concern: Saratoga Investment Adds a New Debt & Financing Risk

In a report released today, Mitchel Penn from Oppenheimer maintained a Buy rating on Saratoga Investment (SAR – Research Report), with a price targ...

Oppenheimer Reaffirms Their Buy Rating on Saratoga Investment (SAR)

Maxim Group analyst Michael Diana has reiterated their bullish stance on SAR stock, giving a Buy rating yesterday. Michael Diana's Buy rating for S...

Saratoga Investment's Dividend Increase and Solid Financial Outlook Justify Buy Rating Despite NAV Dip

BDC Weekly Review: Canary In The Coalmine SAR Is Showing Signs Of Fatigue

Saratoga Investment Corp: 12% Yield, 16% Discount, Buy Rating

Saratoga Investment (Down Big): 40+ Big-Yield BDCs Compared

Silver Spike Investment: Cannabis BDC With Attractive Dividends

Saratoga Investment raises dividend by 1% to $0.73

Saratoga Investment Corp: The Leverage Is Too Excessive For Going Long

Saratoga Investment Corp: Collect A 12.4% Yield With This BDC, But Proceed With Caution

ARCC

BIZD

BXSL

CCAP

CSWC

CSWCZ

CURLF

GAIN

GAINL

GAINN

GAINZ

GBDC

HCXY

HRZN

HTFB

HTFC

HTGC

IIPR

MAIN

OBDC

OCSL

OXSQ

OXSQG

OXSQZ

SSIC

TPVG

TRIN

TRINL

Press Releases

Saratoga Investment Corp. Announces Fiscal First Quarter 2024 Financial Results

Saratoga Investment Corp. Increases Quarterly Dividend by $0.01, or 1.4%, to $0.71 per Share for the Fiscal Second Quarter Ended August 31, 2023

Saratoga Investment Corp. Announces Distribution of Proxy Materials for its 2023 Annual Meeting of Stockholders

Saratoga Investment Corp. to Report Fiscal Second Quarter 2024 Financial Results and Hold Conference Call

Saratoga Investment Corp. Announces Fiscal Second Quarter 2024 Financial Results

Saratoga Investment Corp. Increases Quarterly Dividend by $0.01, or 1.4%, to $0.72 per Share for the Fiscal Third Quarter Ended November 30, 2023

Saratoga Investment Corp. to Report Fiscal Third Quarter 2024 Financial Results and Hold Conference Call

Saratoga Investment Corp. Announces Fiscal Third Quarter 2024 Financial Results

Saratoga Investment Corp. Increases Quarterly Dividend by $0.01, or 1.4%, to $0.73 per Share for the Fiscal Fourth Quarter Ended February 29, 2024

Saratoga Investment Corp. to Report Fiscal Fourth Quarter 2024  Financial Results and Hold Conference Call

AlTi Global

ArrowMark Financial Corp. - Closed End Fund

ArrowMark Financial